Stereotaxis Inc Cash Flow Conversion Efficiency
Stereotaxis Inc cash flow conversion efficiency. Based on the latest financial reports, Stereotaxis Inc (STXS) has a cash flow conversion efficiency ratio of -0.364x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.20 Million) by net assets ($11.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Stereotaxis Inc (2002–2024)
Cash flow conversion efficiency of Stereotaxis Inc from 2002 to 2024. This chart illustrates how Stereotaxis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Stereotaxis Inc stock price for real-time trading data and today's change.
Stereotaxis Inc Cash Flow Conversion Ratio Explained
Stereotaxis Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Stereotaxis Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Stereotaxis Inc ranked by their cash flow conversion efficiency. Also see STXS company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Twelve Seas Investment Co II
NASDAQ:TWLV
|
-0.001x |
|
Inogen Inc
NASDAQ:INGN
|
-0.037x |
|
JF Technology BHD
KLSE:0146
|
-0.007x |
|
Nitco Limited
NSE:NITCO
|
-0.205x |
|
Omaxe Limited
NSE:OMAXE
|
0.064x |
|
Dynamix Corporation
NASDAQ:ETHM
|
0.214x |
|
Astron Corporation Ltd
AU:ATR
|
-0.020x |
|
Marblegate Acquisition Corp
NASDAQ:GATE
|
0.017x |
Annual Cash Flow Conversion Efficiency for Stereotaxis Inc (2002–2024)
The table below shows the annual cash flow conversion efficiency of Stereotaxis Inc from 2002 to 2024. Review Stereotaxis Inc free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $11.43 Million | $-8.50 Million | -0.743x | -78.27% |
| 2023-12-31 | $21.92 Million | $-9.14 Million | -0.417x | -58.19% |
| 2022-12-31 | $31.93 Million | $-8.41 Million | -0.264x | -252.70% |
| 2021-12-31 | $39.42 Million | $-2.95 Million | -0.075x | +14.40% |
| 2020-12-31 | $40.23 Million | $-3.51 Million | -0.087x | +46.06% |
| 2019-12-31 | $28.52 Million | $-4.62 Million | -0.162x | +53.78% |
| 2018-12-31 | $7.27 Million | $-2.55 Million | -0.350x | -254.38% |
| 2017-12-31 | $-20.61 Million | $-4.67 Million | 0.227x | -46.32% |
| 2016-12-31 | $-15.53 Million | $-6.56 Million | 0.423x | +194.59% |
| 2015-12-31 | $-17.63 Million | $-2.53 Million | 0.143x | -80.20% |
| 2014-12-31 | $-12.55 Million | $-9.09 Million | 0.724x | +33.90% |
| 2013-12-31 | $-11.70 Million | $-6.33 Million | 0.541x | -16.10% |
| 2012-12-31 | $-18.79 Million | $-12.12 Million | 0.645x | -61.54% |
| 2011-12-31 | $-18.83 Million | $-31.57 Million | 1.677x | +192.88% |
| 2010-12-31 | $10.48 Million | $-18.91 Million | -1.805x | +38.17% |
| 2009-12-31 | $7.64 Million | $-22.31 Million | -2.919x | +51.39% |
| 2008-12-31 | $4.77 Million | $-28.65 Million | -6.006x | -306.91% |
| 2007-12-31 | $24.19 Million | $-35.71 Million | -1.476x | -69.60% |
| 2006-12-31 | $44.79 Million | $-38.98 Million | -0.870x | +61.51% |
| 2005-12-31 | $18.13 Million | $-40.99 Million | -2.261x | -315.04% |
| 2004-12-31 | $58.39 Million | $-31.81 Million | -0.545x | +43.74% |
| 2003-12-31 | $25.27 Million | $-24.47 Million | -0.968x | -5.54% |
| 2002-12-31 | $24.01 Million | $-22.03 Million | -0.918x | -- |
About Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires thro… Read more